Related Experiment Video
Updated: Apr 22, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP
D Hühn1, A N Kousholt2, C S Sørensen2
1Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Abstract:
MicroRNA-19 (miR-19) was recently identified as the key oncogenic component of the polycistronic miR-17∼92 cluster, also known as oncomiR-1, which is frequently upregulated or amplified in multiple tumor types. However, the gene targets and the pathways underlying the tumor-promoting activity of miR-19 still remain largely elusive. CtIP/RBBP8 promotes DNA-end resection, a critical step in the repair of DNA double-strand breaks (DSBs) by homologous recombination (HR), and is considered to function as a tumor suppressor. In this study, we show that miR-19 downregulates CtIP expression by binding to two highly conserved sequences located in the 3'-untranslated region of CtIP mRNA. We further demonstrate that CtIP expression is repressed by miR-19 during continuous genotoxic stress in a p53-dependent manner. Finally, we report that miR-19 impairs CtIP-mediated DNA-end resection, which results in reduced HR levels and DNA damage hypersensitivity. By downregulating CtIP, miR-19 overexpression suppresses the faithful repair of DSBs that is crucial for genome maintenance. Our findings thus provide new mechanistic insight into the oncogenic role of the miR-17∼92 cluster.
Insights
MicroRNA-19 (miR-19) promotes cancer by downregulating CtIP, a protein crucial for repairing DNA double-strand breaks (DSBs). This impairs homologous recombination (HR) repair, leading to DNA damage hypersensitivity and genomic instability.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The miR-17∼92 cluster, known as oncomiR-1, contains microRNA-19 (miR-19) as a key oncogenic component frequently amplified in tumors.
- The tumor-promoting mechanisms of miR-19 are not fully understood, particularly its gene targets and affected pathways.
- CtIP (RBBP8) is a tumor suppressor involved in DNA double-strand break (DSB) repair via homologous recombination (HR).
Purpose of the Study:
- To investigate the gene targets and molecular mechanisms underlying the oncogenic activity of miR-19.
- To determine if miR-19 directly targets CtIP and affects its function in DNA repair.
Main Methods:
- Bioinformatic analysis to identify potential miR-19 binding sites on CtIP mRNA.
- Western blotting and qRT-PCR to assess CtIP expression levels after miR-19 manipulation.
- DNA combing and gamma-H2AX foci assays to evaluate DNA-end resection and DSB repair efficiency.
- Cellular assays to assess DNA damage hypersensitivity and homologous recombination (HR) levels.
Main Results:
- miR-19 directly downregulates CtIP expression by binding to conserved sites in its 3'-untranslated region.
- CtIP expression is repressed by miR-19 under genotoxic stress in a p53-dependent manner.
- miR-19 overexpression impairs CtIP-mediated DNA-end resection, reducing HR and causing DNA damage hypersensitivity.
Conclusions:
- miR-19 acts as an oncoprotein by inhibiting CtIP-dependent DNA repair pathways.
- Downregulation of CtIP by miR-19 disrupts faithful DSB repair, contributing to genome instability and tumor progression.
- These findings elucidate a novel mechanism for the oncogenic role of the miR-17∼92 cluster.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
Long-patch Base Excision Repair
DNA Helicases
Telomeres and Telomerase

